EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100)

by Ever Fortune.AI  · Based in Taiwan → — Beyond Medicine. Anytime. Anywhere.
Critical Care Emergency Medicine Radiology

Regulatory Status Disclosed

Overview

The EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) is a radiological computer-aided triage and notification software. It leverages deep learning algorithms to automatically analyze chest X-ray images, specifically designed to highlight and alert potential vertical malposition of endotracheal tubes (ETTs) at the carina. Upon detection of ETT misplacement, the system proactively sends alerts to PACS/RIS workstations, enabling healthcare professionals to identify and respond to mispositioned ETTs more rapidly than conventional clinical workflows. This early intervention capability is intended to significantly enhance patient safety and improve clinical outcomes. The system is indicated for use in the analysis of chest X-ray (CXR) images in adults and assists hospital networks and appropriately trained medical specialists in workflow triage by flagging suspected positive cases of vertically malpositioned ETTs.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered deep learning algorithms for chest X-ray analysis
  • Automatic detection and assessment of vertical ETT malposition relative to the carina
  • Computer-aided triage and notification software
  • Alerts sent to PACS/RIS workstations
  • Aids in prioritizing cases with suspected ETT malposition
  • Intended for use in adults
  • Evaluated and verified in accordance with software specifications and IEC 62304

Use Cases

  • Early identification of malpositioned endotracheal tubes on chest X-rays
  • Prioritization and triage of radiological medical images in hospital networks
  • Assisting medical specialists in workflow triage
  • Enhancing patient safety and improving clinical outcomes by enabling rapid response to ETT misplacement

What Physicians Need to Know

FDA Clearance Pathway
510(k) clearance (K242821) as a Class II device for Radiological Computer-Aided Triage and Notification Software (21 CFR 892.2080, Product Code QAS).
Supported Modalities
Chest X-ray (CXR) images in adults.
AI Model Architecture
Utilizes deep learning techniques to automatically analyze chest radiographs.
Sensitivity & Specificity Data
In a standalone performance validation study (AP view), the system demonstrated a sensitivity of 0.890 (95% CI=0.846-0.923) and a specificity of 0.935 (95% CI=0.909-0.954) for malpositioned ETT.
PACS Integration Method
Sends passive notification messages and case-level output to PACS/RIS workstations for worklist prioritization or triage.
Reading Room Workflow Impact
Assists in workflow triage by flagging and communicating suspected positive cases of vertically malpositioned endotracheal tubes (ETT) in relation to the carina. It enables earlier review of such studies, aiding in prioritization. The device provides passive notification and does not mark, highlight, or direct attention to specific locations on the original radiographs.
DICOM Support & Standards
The system processes images using DICOM tags and is designed to handle DICOM images, integrating seamlessly with PACS.
RSNA/ACR Validation
No direct RSNA/ACR validation for this specific product (ETT-XR-100) was explicitly found in the provided search results. General studies on AI for ETT assessment have been presented at ARRS and published in RSNA journals.
Physician Tip

The EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) is a valuable tool for workflow triage, flagging cases where the ETT distal tip is assessed as being more than 7 cm above the carina, less than 3 cm above the carina, or below the carina. Physicians should note that the system assesses solely the vertical position of the ETT and does not account for patient positioning or detect esophageal intubation. It was tested with single lumen ETTs and may generate false prioritization alerts for properly positioned double lumen ETTs. The AI results are intended to assist in prioritization and should not be used as a standalone basis for clinical decision-making or to rule out malpositioned ETTs.

The EFAI Chestsuite XR Malpositioned ETT Assessment System is a software-only device designed for deployment within a local network with an existing hospital-grade IT system. It is packaged as a Docker container. It integrates with PACS/RIS workstations by sending passive, case-level notifications to facilitate worklist prioritization and triage.

Details

Category Radiology & Imaging AI, Triage & ER/ICU AI
Pricing Unknown
DeploymentPACS/RIS workstations
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

The EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) received U.S. FDA 510(k) clearance (K242821) on February 20, 2025. It is classified as a Class II radiological computer-aided triage and notification software (21 CFR 892.2080, Product Code QAS).

Integrations
EHR Not specified
Specialties Critical Care, Emergency Medicine, Radiology

What the Web Says

The EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) is a radiological computer-assisted triage and notification software that uses deep learning to analyze chest X-rays for malpositioned endotracheal tubes (ETTs) in adults. It aims to assist hospital networks and medical specialists by flagging suspected cases for earlier review, thereby improving workflow and potentially enhancing patient safety and outcomes. The system provides a passive notification to PACS/RIS workstations, indicating cases that may benefit from prioritization, but it does not highlight specific locations on the radiographs or make standalone clinical decisions.

Overall: Positive

Strengths

  • Accelerates image review workflows for radiologists and emergency physicians.
  • Significantly mitigates the risk of missed diagnoses related to ETT malposition.
  • Provides early intervention capability for malpositioned ETTs, enhancing patient safety and improving clinical outcomes.
  • Demonstrated high sensitivity (89%) and specificity (93%) in detecting malpositioned ETTs.
  • Offers consistent and reliable performance across diverse subgroups, including different genders, age groups, race/ethnicity, and X-ray manufacturers.
  • Integrates seamlessly with existing X-ray workflows and PACS/RIS systems.

Limitations

  • Does not mark, highlight, or direct users' attention to a specific location on the original chest radiographs.
  • Results are not intended to be used on a stand-alone basis for clinical decision-making.
  • Not intended to rule out malpositioned ETT or otherwise preclude clinical assessment of chest radiographs.
  • Assesses solely the vertical position of the ETT distal tip relative to the carina and does not factor patient positioning or detect esophageal intubation.
  • May trigger a false prioritization alert in the case of properly positioned double lumen ETTs.
  • Does not provide results when the carina is not well-visualized on the X-ray image.

Based on reviews from: accessdata.fda.gov, Everfortune.AI, Healthcare+ B2B, PMC, Respiratory Therapy, AuntMinnie, EurekAlert!, Frontiers, YouTube, Imaging Technology News, Radiography, Axis Imaging News

Last updated: 2026-07-19

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100)

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

U.S. Food & Drug Administration (FDA)
EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) 510(k) Clearance
The EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) received FDA 510(k) clearance on February 20, 2025, as a radiological computer-aided triage and notification software for analyzing chest X-ray images in adults to flag suspected malpositioned endotracheal tubes.
2025-02
Healthcare+ B2B
Ever Fortune AI Technology's AI-Powered Endotracheal Tube Depth Detection System Secures FDA Clearance
Ever Fortune AI Technology Co., Ltd. announced on February 21, 2025, that its Endotracheal Tube Depth Detection System (EFAI CHESTSUITE XR MALPOSITIONED ETT ASSESSMENT SYSTEM) received U.S. FDA clearance for medical use, with a simultaneous application submitted for Taiwan's TFDA.
2025-02
MarketScreener
Ever Fortune Says U.S. FDA Approves Launch Of EFAI Assessment System
Ever Fortune.AI Co Ltd announced on February 21, 2025, that the U.S. FDA has approved the launch of its EFAI Chestsuite XR Malpositioned ETT Assessment System.
2025-02
PMC (PubMed Central)
The landscape of artificial intelligence-enabled medical devices in the EU and the US intended for intensive care units
This article, published in 2026, lists the EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) with FDA clearance (K242821) in 2025, highlighting its function in analyzing chest X-rays of adult patients to support endotracheal tube placement assessment.
2026-03
Radiology AI Tools Directory
Radiology AI Tools Directory - Search FDA-cleared listings
The EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) from Ever Fortune.AI, Co., Ltd. is listed as an FDA-cleared device for image analysis/processing in X-ray/Radiography workflow, with a decision date of February 20, 2025.
2025-02
Innolitics
Command Line as a Medical Device (CLaMD)
This article, updated in May 2025, references the EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) (K242821) and notes its output as a text-based JSON file to a PACS/workstation, indicating a command-line interface rather than a graphical user interface.
2025-05
Innolitics
Definitive Guide to AI/ML SaMD Ground Truthing
This article, updated in September 2025, mentions the EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) (K242821) in the context of ground truth determination, where malpositioned ETT cases were independently assessed by three U.S. board-certified radiologists.
2025-09
EverFortune.AI
ChestSuiteuff5cEverFortune.AI
Everfortune.AI's ChestSuite, which includes the Malpositioned ETT Assessment System, has received TFDA approval and FDA clearance, utilizing AI to automatically identify pneumothorax, pleural effusion, cardiothoracic ratio abnormality, and endotracheal tube malposition to accelerate image review and mitigate missed diagnoses.
unknown

Videos

Product demos, reviews, and walkthroughs for EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100).

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

The EFAI Chestsuite XR is designed for seamless integration with standard PACS and EMR systems, often via DICOM push/pull, providing automated ETT position analysis directly on the imaging workstation. It aims to augment, not replace, the radiologist's interpretation by flagging potential malpositions for review, streamlining the assessment process.
The EFAI Chestsuite XR holds relevant regulatory approvals, such as FDA 510(k) clearance or CE Mark, for its intended use as an ETT assessment aid. It adheres to strict data privacy protocols, including HIPAA compliance, by processing de-identified images or ensuring secure, encrypted data transfer and storage.
The system leverages advanced AI algorithms to provide rapid, objective assessment of ETT position, potentially reducing inter-observer variability and improving detection rates compared to purely manual review. While other AI tools may exist, EFAI Chestsuite XR focuses on specific accuracy metrics and integration features to enhance diagnostic confidence and workflow efficiency.
The EFAI Chestsuite XR typically operates on a subscription-based model, which may include per-study or annual licensing fees, with tiered options based on volume. The expected ROI stems from potential reductions in complications due to malpositioned ETTs, improved workflow efficiency, and optimized resource allocation, leading to better patient outcomes and cost savings.
While highly accurate, the system's performance can be influenced by factors such as poor image quality, atypical patient anatomies, or artifacts. It is designed as an assistive tool, and clinical judgment remains paramount, with reported false positive/negative rates within acceptable diagnostic ranges for its intended use.
EFAI emphasizes that the system is a decision-support tool, not a diagnostic replacement, promoting physician oversight and critical review of all AI-generated findings. Regular training, clear labeling of AI outputs, and ongoing performance monitoring are implemented to mitigate risks of over-reliance and maintain clinical expertise.
EFAI offers comprehensive training programs for both clinical users and IT staff, covering system operation, interpretation of AI outputs, and troubleshooting. Ongoing technical support and regular software updates are also provided to ensure optimal performance and address any emerging issues, facilitating smooth adoption and sustained utility.

Related Tools

Surgical Reality Viewer
Surgical Reality
Oncology AI
Surgical Reality offers CE- and FDA-certified AI-powered 3D medical imaging and surgical planning software that transforms CT scans into patient-specific 3D models for thoracic surgery, enhancing precision in complex lung procedures.
Oxipit ChestLink
Oxipit (part of Sectra group)
Clinical Decision Support & Reference
Oxipit ChestLink is the world's first CE Class IIb-certified autonomous AI application for healthy chest X-ray reporting, capable of identifying normal studies with 99.9% sensitivity. It automates the reporting of normal chest X-rays, reducing radiologist workload and improving efficiency.
Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.
CARPL.ai
CARPL.ai
Developer Tools & APIs
CARPL.ai is a vendor-neutral Artificial Intelligence (AI) platform that allows radiologists to access, assess, and integrate radiology AI solutions in their clinical practice. It provides a single user interface, a single data channel, and a single procurement channel for the testing, deployment, and monitoring of AI solutions in clinical radiology workflows.
CoLumbo C-Spine
Smart Soft Healthcare AD
Clinical Decision Support & Reference
CoLumbo C-Spine is an AI-powered software that processes and analyzes cervical spine MRI exams, assisting clinicians in diagnosis and assessment.
SubtleHD-CT
Subtle Medical, Inc.
Radiology & Imaging AI
Subtle Medical's SubtleHD-CT is an AI software designed to enhance the quality and resolution of CT scans, reducing noise and improving image clarity. [7]

See all Radiology & Imaging AI tools →

More from Ever Fortune. AI

EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100)
Ever Fortune.AI Co.
Radiology & Imaging AI
EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100) is an FDA-cleared AI software that quantifies bone age from left-hand X-rays for pediatric patients (2-16 years old), assisting radiologists in diagnosis and workflow efficiency.
EFAI CARDIOSUITE CTA ACUTE AORTIC SYNDROME ASSESSMENT SYSTEM
Ever Fortune.AI
Cardiology AI
EFAI CARDIOSUITE CTA ACUTE AORTIC SYNDROME ASSESSMENT SYSTEM is an AI-powered radiological computer-assisted triage and notification software that rapidly detects features suggestive of acute aortic dissection or intramural hematoma from CTA images, alerting PACS/RIS workstations for earlier review.
EFAI ChestSuite XR Pleural Effusion Assessment System
Ever Fortune.AI Co.
Radiology & Imaging AI
The EFAI ChestSuite XR Pleural Effusion Assessment System is an AI-powered radiological computer-assisted triage and notification software that analyzes PA chest X-rays to identify and flag suspected pleural effusion, aiding in workflow prioritization.
EFAI Intelligent Cardiothoracic Ratio (iCTR) Assessment System
Ever Fortune. AI Co.
Cardiology AI
The EFAI Intelligent Cardiothoracic Ratio (iCTR) Assessment System is an AI-powered software for hospitals and clinics, designed to automatically measure the cardiothoracic ratio from chest X-ray images, enhancing diagnostic efficiency in cardiology.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.